Skip to main content

Table 2 Distribution of characteristics among participants at baseline and endline evaluation of an OSTPP, in Kabul, Afghanistan

From: Cross-sectional assessments of participants’ characteristics and loss to follow-up in the first Opioid Substitution Therapy Pilot Program in Kabul, Afghanistan

Characteristics

Baseline participants (N = 83)

Endline participants (N = 57)

p value

n (%)

n (%)

Mental health symptom median (SD)

6 (24.1)

3.0 (3.7)

<0.001

General health symptom median (SD)

5.0 (2.1)

8.0 (1.7)

<0.001

Current heroin use (any type)

83 (100)

35 (61.4)a

<0.001

Correct HIV knowledge

50 (60.2)

43 (75.4)

0.07

Has source of income

17 (20.5)

48 (84.2)

<0.001

History of criminal activity

51 (61.5)

0 (0)

<0.001

Any family contact

21 (25.3)

41 (71.9)

<0.001

  1. aAt endline, 15 participants (26.3 %) reported injecting heroin at some point after enrollment. Two participants (3.5 %) reported injecting in the last month
  2. bAll six characteristics presented in column one reflect the characteristic reported before enrollment vs. characteristic reported after enrollment